Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors
Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors is a paper indexed in PICO Portal from OpenAlex.
How many citations does Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors have?
Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors has 11 citations in the OpenAlex counts PICO Portal stores.
When was Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors published?
Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors has 2023 year in the PICO Portal index.
What is the open-access status of Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors?
Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors has diamond oa status in the PICO Portal index.
What is the DOI of Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors?
The DOI for Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors is on the source record.
What is the PMID of Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors?
The PMID for Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors is on the source record.
What is the OpenAlex record for Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors?
The OpenAlex for Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors is on the source record.